MetLife Investment Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $20.7K | Sell |
|
|||||
|
2024
Q4 | $99.1K | Hold |
|
|||||
|
2024
Q3 | $138K | Buy |
|
|||||
|
2024
Q2 | $57.7K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $42.8K | Sell |
|
|||||
|
2022
Q4 | $215K | Hold |
|
|||||
|
2022
Q3 | $304K | Hold |
|
|||||
|
2022
Q2 | $361K | Buy |
|
|||||
|
2022
Q1 | $19.4K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $1.59M | Sell |
|
|||||
|
2021
Q2 | $1.56M | Sell |
|
|||||
|
2021
Q1 | $1.88M | Sell |
|
|||||
|
2020
Q4 | $1.67M | Sell |
|
|||||
|
2020
Q3 | $1.7M | Sell |
|
|||||
|
2020
Q2 | $2.45M | Buy |
|
|||||
|
2020
Q1 | $1.8M | Hold |
|
|||||
|
2019
Q4 | $2.18M | Buy |
|
|||||
|
2019
Q3 | $869K | Sell |
|
|||||
|
2019
Q2 | $1.71M | Sell |
|
|||||
|
2019
Q1 | $1.66M | Hold |
|
|||||
|
2018
Q4 | $1.63M | Sell |
|
|||||
|
2018
Q3 | $3.06M | Buy |
|
|||||
|
2018
Q2 | $2.32M | Sell |
|
|||||
|
2018
Q1 | $12.3M | Buy |
|
|||||
|
2017
Q4 | $4M | Buy |
|